Merck & Co. Inc. (MRK)
Merck & Statistics
Share Statistics
Merck & has 2.53B shares outstanding. The number of shares has increased by -0.27% in one year.
| Shares Outstanding | 2.53B |
| Shares Change (YoY) | -0.27% |
| Shares Change (QoQ) | -0.14% |
| Owned by Institutions (%) | 77.8% |
| Shares Floating | 2.52B |
| Failed to Deliver (FTD) Shares | 94.1K |
| FTD / Avg. Volume | 0.53% |
Short Selling Information
The latest short interest is 34.12M, so 1.35% of the outstanding shares have been sold short.
| Short Interest | 34.12M |
| Short % of Shares Out | 1.35% |
| Short % of Float | 1.35% |
| Short Ratio (days to cover) | 3.46 |
Valuation Ratios
The PE ratio is 14.77 and the forward PE ratio is 10.49. Merck &'s PEG ratio is 0.
| PE Ratio | 14.77 |
| Forward PE | 10.49 |
| PS Ratio | 3.94 |
| Forward PS | 2.8 |
| PB Ratio | 5.46 |
| P/FCF Ratio | 13.97 |
| PEG Ratio | 0 |
Enterprise Valuation
Merck & has an Enterprise Value (EV) of 276.65B.
| EV / Sales | 4.31 |
| EV / EBITDA | 10.27 |
| EV / EBIT | 12.89 |
| EV / FCF | 15.29 |
Financial Position
The company has a current ratio of 1.36, with a Debt / Equity ratio of 0.8.
| Current Ratio | 1.36 |
| Quick Ratio | 1.15 |
| Debt / Equity | 0.8 |
| Debt / EBITDA | 1.38 |
| Debt / FCF | 2.05 |
| Interest Coverage | 0 |
Financial Efficiency
Return on Equity is 36.96% and Return on Invested Capital is 37.86%.
| Return on Equity | 36.96% |
| Return on Assets | 22.15% |
| Return on Invested Capital | 37.86% |
| Revenue Per Employee | $879.01K |
| Profits Per Employee | $234.48K |
| Employee Count | 73,000 |
| Asset Turnover | 0.83 |
| Inventory Turnover | 2.01 |
Taxes
| Income Tax | 2.8B |
| Effective Tax Rate | 14.06% |
Stock Price Statistics
The stock price has increased by -37.07% in the last 52 weeks. The beta is 0.42, so Merck &'s price volatility has been higher than the market average.
| Beta | 0.42 |
| 52-Week Price Change | -37.07% |
| 50-Day Moving Average | 89.36 |
| 200-Day Moving Average | 104.64 |
| Relative Strength Index (RSI) | 32.29 |
| Average Volume (20 Days) | 17.71M |
Income Statement
In the last 12 months, Merck & had revenue of 64.17B and earned 17.12B in profits. Earnings per share was 6.74.
| Revenue | 64.17B |
| Gross Profit | 51.88B |
| Operating Income | 22.69B |
| Net Income | 17.12B |
| EBITDA | 26.94B |
| EBIT | 22.77B |
| Earnings Per Share (EPS) | 6.74 |
Balance Sheet
The company has 13.24B in cash and 37.11B in debt, giving a net cash position of -23.87B.
| Cash & Cash Equivalents | 13.24B |
| Total Debt | 37.11B |
| Net Cash | -23.87B |
| Retained Earnings | 0 |
| Total Assets | 117.11B |
| Working Capital | 10.36B |
Cash Flow
In the last 12 months, operating cash flow was 21.47B and capital expenditures -3.37B, giving a free cash flow of 18.1B.
| Operating Cash Flow | 21.47B |
| Capital Expenditures | -3.37B |
| Free Cash Flow | 18.1B |
| FCF Per Share | 7.12 |
Margins
Gross margin is 80.85%, with operating and profit margins of 35.36% and 26.68%.
| Gross Margin | 80.85% |
| Operating Margin | 35.36% |
| Pretax Margin | 31.07% |
| Profit Margin | 26.68% |
| EBITDA Margin | 41.98% |
| EBIT Margin | 35.36% |
| FCF Margin | 28.2% |
Dividends & Yields
MRK pays an annual dividend of $3.16, which amounts to a dividend yield of 3.33%.
| Dividend Per Share | $3.16 |
| Dividend Yield | 3.33% |
| Dividend Growth (YoY) | 5.19% |
| Payout Ratio | 46.88% |
| Earnings Yield | 6.77% |
| FCF Yield | 7.16% |
Analyst Forecast
The average price target for MRK is $111, which is 40.3% higher than the current price. The consensus rating is "Buy".
| Price Target | $111 |
| Price Target Difference | 40.3% |
| Analyst Consensus | Buy |
| Analyst Count | 13 |
Stock Splits
The last stock split was on Jun 3, 2021. It was a forward split with a ratio of 131:125.
| Last Split Date | Jun 3, 2021 |
| Split Type | forward |
| Split Ratio | 131:125 |
Scores
| Altman Z-Score | 2.99 |
| Piotroski F-Score | 8 |